Latest filing published 15 Jul 2026 for MoonLake Immunotherapeutics, €2.5M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Reich Kristian appears in our data through filings on MoonLake Immunotherapeutics shares, published by SEC (Form 4). Between 15 June 2026 and 15 July 2026, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 15 July 2026, reports a transaction of €2.5M in MoonLake Immunotherapeutics. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations